Brca1 is expressed independently of hormonal stimulation in the mouse ovary

Laboratory Investigation

Volumn 76, Issue 3, 1997, Pages 419-425

  Phillips, Katherine W ^a   Goldsworthy, Susan M ^b   Bennett, L Michelle ^a   Brownlee, Heather A ^a   Wiseman, Roger W ^a   Davis, Barbara J ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b Pathology Associates International   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; ESTROGEN RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SUSCEPTIBILITY; CELL CYCLE; CONTROLLED STUDY; CORPUS LUTEUM; GENE EXPRESSION REGULATION; GENE MUTATION; GRANULOSA CELL; HORMONAL REGULATION; HYPOPHYSECTOMY; LUTEAL CELL; MOUSE; NONHUMAN; OVARY CANCER; OVARY FOLLICLE DEVELOPMENT; PRIORITY JOURNAL; THECA CELL;

ANIMALS; BRCA1 PROTEIN; CELL CYCLE; CHORIONIC GONADOTROPIN; CORPUS LUTEUM; ESTRUS; FEMALE; GRANULOSA CELLS; HYPOPHYSECTOMY; IN SITU HYBRIDIZATION; LACTATION; MICE; OVARIAN FOLLICLE; OVARY; PREGNANCY; PREGNANCY, ANIMAL; RECEPTORS, ESTROGEN; THECA CELLS;

EID: 0030948597     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Chen Y, Farmer A, Chen C, Jones D, Chen P, and Lee W (1996). BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. Cancer Res 56:3168-3172.
2. Couse JF, Curtis SW, Washburn TF, Eddy EM, Schomberg DW, and Korach KS (1995). Disruption of the mouse oestrogen receptor gene: Resulting phenotypes and experimental findings. Biochem Soc Trans 23:929-935.
3. Goldsmith L and Hirshfield A (1991). Evidence for luteal cell hyperplasia during pregnancy. Biol Reprod 44:511-515.
4. Gudas JM, Li T, Nguyen H, Jensen D, and Cowan KH (1996). Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells. Cell Growth Diff 7:717-723.
5. Gudas JM, Nguyen H, Li T, and Cowan KH (1995). Hormone-dependent regulation of BRCA1 in human breast cancer cells. Cancer Res 55:4561-4565.
6. Holt JT, Thompson ME, Szabo C, Robinson-Benion C, Arteaga CL, King MC, and Jenson RA (1996). Growth retardation and tumour inhibition by BRCA1. Nat Genet 12:298-302.
7. Jensen RA, Thompson ME, Jetton TL, Szabo Cl, van der Meer R, Helou B, Tronick SR, Page DL, King M, and Holt JT (1996). BRCA1 is secreted and exhibits properties of a granin. Nat Genet 12:303-308.
8. Lane TF, Deng C, Elson A, Lyu MS, Kozak CA, and Leder P (1995). Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. Genes Dev 9:2712-2722.
9. Liu J, Phillips K, Foley J, and Maronpot R (1995). Optimizing in situ hybridization of lactoferrin mRNA in mouse uterus tissue suing digoxigenin-labeled RNA probes. Cell Vision 2:430-434.
10. Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, and Smithies O (1993). Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci USA 90:11162-11166.
11. Marquis ST, Rajan JV, Wynshaw-Boris A, Xu J, Yin G-Y, Abel KJ Weber BL, and Chodosh LA (1995). The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues. Nat Genet 11:17-26.
12. Miki Y Swensen J, Shattuck-Eidens D, Futreal P, Harshman K Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Borgden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow P, Norris F, Helvering L, Morrison P, Roseteck P, Lai M, Barrett JC, Lewis C Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, and Skolnick MH (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71.
13. Norris J, Fan D, Aleman C, Marks J, Futreal P, Wiseman R, Iglehart J, Deininger P, and McDonald D (1995). Identification of a new subclass of Alu DNA repeats which can function as estrogen receptor-dependent transcriptional enhancers. J Biol Chem 270:22777-22782.
14. Pedersen T (1970). Cell kinetics in the ovary of the cyclic mouse. Acta Endocrinol 64:304-323.
15. Pedersen T and Peters H (1968). Proposal for a classification of oocytes and follicles in the mouse ovary. J Reprod Fert 17:555-557.
16. Pedersen T and Peters H (1971). Follicle growth and cell dynamics in the mouse ovary during pregnancy. Fertil Steril 22:42-52.
17. Richards JS and Hedin L (1988). Molecular aspects of hormone action in ovarian follicular development, ovulation and luteinization. Ann Rev Physiol 50:441-463.
18. Stratton MR (1996). Recent advances in understanding of genetic susceptibility to breast cancer. Hum Mol Genet 5:1515-1519.
19. Tsutsumi Y, Serizawa A, and Kawai K (1995). Enhanced polymer one-step staining (EPOS) for proliferating cell nuclear antigen (PCNA) and Ki-67 antigen: Application to intra-operative frozen diagnosis. Pathol Int 45:108-115.
20. Vaughn J, Davis P, Jarboe M, Huper G, Evans A, Wiseman R, Berchuck A, Iglehart J, Futreal P, and Marks J (1996). BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells. Cell Growth Diff 7:711-715.
21. Wang X and Greenwald G (1993). Hypophysectomy of the cyclic mouse: I - Effects on folliculogenesis, oocyte growth and FSH- and hCG-receptors. Biol Reprod 48:585-594.